US2008139845A1PendingUtilityA1
Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
Est. expiryDec 12, 2026(~0.4 yrs left)· nominal 20-yr term from priority
C07F 9/3873A61P 19/10A61K 31/663
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel form of Ibandronate sodium which is particularly suitable for pharmaceutical applications, and a process for preparing said novel form.
Claims
exact text as granted — not AI-modified1 . The preparation of Ibandronic acid and its sodium salt comprising reacting 3-(N-methylpentylamino)propanoic acid, or it's hydrochloride salt, phosphorous acid and phosphorous trichloride in the presence of polyethylene glycol.
2 . The preparation of Ibandronic acid and its sodium salt according to claim 1 wherein the polyethylene glycol has an average molecular weight of about 400.
3 . The preparation of Ibandronic acid and its sodium salt according to claim 1 or 2 wherein the phosphorylation reaction is performed at about 45° C. to about 70° C.
4 . The preparation of Ibandronic acid and its sodium salt according to claim 1 or 2 wherein the phosphorylation reaction is performed at about 55° C. to about 60° C.
5 . The preparation of Ibandronic acid and its sodium salt according to claim 3 or 4 wherein the phosphorylation reaction is performed in about 0.8 to about 2 volumes of polyethylene glycol.
6 . The preparation of Ibandronic acid and its sodium salt according to claim 3 or 4 wherein the phosphorylation reaction is performed using about 0.8 to about 2.0 equivalents of phosphorous acid and phosphorous trichloride relative to the amount of 3-(N-methyl-N-pentylamino)propanoic acid substrate.
7 . The preparation of Ibandronic acid and its sodium salt according to claim 3 or 4 wherein the phosphorylation reaction is performed using about 1.0 to about 1.6 equivalents of phosphorous acid and phosphorous trichloride relative to the amount of 3-(N-methyl-N-pentylamino)propanoic acid substrate.
8 . The preparation of Ibandronic acid and its sodium salt according to claims 1 , 2 or 3 wherein the phosphorylation reaction is performed in the presence of a co-solvent.
9 . The preparation of Ibandronic acid and its sodium salt according to claim 8 wherein the phosphorylation reaction is performed in the presence of toluene as a co-solvent.
10 . The preparation of Ibandronic acid and its sodium salt according to claim 9 wherein the phosphorylation reaction is performed in a toluene co-solvent where the amount of toluene is about 2 to about 4 volumes, relative to the weight of the 3-(N-methyl-N-pentylamino)propanoic acid substrate.
11 . The preparation of Ibandronate sodium according to claims 1 , 2 or 8 wherein the Ibandronate sodium is further converted to Ibandronate sodium propylene glycolate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.